Skip to main content

Table 4 The relation of 1st follow-up CT lipiodol retention patterns with final progression statuses and time from cTACE to recurrence in months

From: Value of computed tomography-based lipiodol retention pattern in the assessment of hepatocellular carcinoma complete response following conventional transarterial chemoembolization

 

Complete lipiodol retention (N = 21)

Incomplete lipiodol retention (N = 9)

P value

Final progression status

No recurrence

16 (76.2%)

1 (11.1%)

0.001

Recurrence

5 (23.8%)

8 (88.9%)

Time from cTACE to recurrence (months)

Mean ± SD

5.57 ± 2.69

6.0 ± 2.27

0.743

Range

3–9

3–9

  1. The statistical methods of Chi-square test and independent t-test were employed to analyze discrete and continuous variables, respectively
  2. C-Lip complete lipiodol retention, cTACE conventional transarterial chemoembolization, DCE-MRI dynamic contrast-enhanced magnetic resonance imaging, I-Lip incomplete lipiodol retention, SD standard deviation